All In MedTech

FDA Clearance Tracker · P160024

LIFESTREAM BALLOON EXPANDABLE VASCULAR COVERED STENT

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Apr 24, 2017 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Apr 24, 2017

Approved

Time to decision

277 days

Received Jul 21, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P160024
Device name
LIFESTREAM BALLOON EXPANDABLE VASCULAR COVERED STENT
Applicant location
Tempe, AZ
Received
Jul 21, 2016
Decided
Apr 24, 2017
Decision
Approved
Supplements
14 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code PRL

FDA's approval statement

As written in FDA's record.

Approval for the LifeStream Balloon Expandable Vascular Covered Stent. This device is indicated for the treatment of atherosclerotic lesions in common and external iliac arteries with reference vessel diameters between 4.5 mm and 12.0 mm, and lesion lengths up to 100 mm.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code PRL. The earliest in FDA's data is P160021, decided Jan 27, 2017.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Bard Peripheral Vascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.